Internal Medicine, Hematology & Oncology · Middletown, NY
NPI
1982715892
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
185 Rykowski Ln
Middletown, NY, 10941
Phone (845) 703-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
127,521 services
Medicare patients, 2024
866
Average age 74
Drug cost, 2024
$4.5M
1,578 prescriptions
Company payments, 2024
$55.88
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey M Stewart was code J1453 (injection, fosaprepitant, 1 mg), 11,400 times for 19 patients. In total Jeffrey M Stewart billed 127,521 services in 153 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 11,400 | 19 | $0.11 | $1,304 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,800 | 11 | $44.57 | $348K |
| 36415 Venipuncture Blood Collection | Office | 2,399 | 691 | $8.65 | $21K |
| 85025 Blood Count | Office | 2,264 | 692 | $7.61 | $17K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,860 | 43 | $0.25 | $467 |
| 99214 Office E&M - Established | Office | 1,827 | 645 | $99.50 | $182K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,562 | 33 | $0.09 | $141 |
| 80053 Clinical Chemistry | Office | 1,351 | 518 | $10.35 | $14K |
| J1750 Injection, iron dextran, 50 mg | Office | 420 | 21 | $13.66 | $5,737 |
| 99232 Hospital E&M - Subsequent | Facility | 328 | 82 | $64.76 | $21K |
| 96375 Injection Administration | Office | 324 | 55 | $13.20 | $4,277 |
| J9045 Injection, carboplatin, 50 mg | Office | 285 | 11 | $2.87 | $817 |
| 96413 Chemotherapy Administration | Office | 275 | 64 | $111.57 | $31K |
| 96372 Injection Administration | Office | 249 | 44 | $12.21 | $3,040 |
| 82728 Clinical Chemistry | Office | 203 | 126 | $13.36 | $2,712 |
By year: 2022 $3.2M for 130,377 services; 2023 $2.4M for 102,477 services; 2024 $2.4M for 127,521 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,399 | 691 | $8.65 | $21K |
| 85025 Blood Count | 2,264 | 692 | $7.61 | $17K |
| 80053 Clinical Chemistry | 1,351 | 518 | $10.35 | $14K |
| 82728 Clinical Chemistry | 203 | 126 | $13.36 | $2,712 |
| 83615 Clinical Chemistry | 156 | 100 | $5.92 | $924 |
| 85610 Clinical Chemistry | 148 | 44 | $4.20 | $622 |
| 82378 Clinical Chemistry | 107 | 46 | $18.58 | $1,988 |
| 85045 Blood Count | 103 | 75 | $3.91 | $403 |
| 84153 Clinical Chemistry | 99 | 45 | $18.02 | $1,784 |
| 82607 Clinical Chemistry | 68 | 60 | $14.78 | $1,005 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey M Stewart prescribed most often to Medicare patients was Eliquis (Apixaban), with 145 prescriptions and refills. In total Jeffrey M Stewart wrote 1,578 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 145 | 163 | 27 | $94K |
| Warfarin Sodium Generic | 142 | 201 | 20 | $841 |
| Anastrozole Generic | 96 | 150 | 16 | $1,326 |
| Xarelto Rivaroxaban | 82 | 113 | 16 | $65K |
| Ondansetron Odt Ondansetron | 70 | 70 | 40 | $914 |
| Abiraterone Acetate Generic | 59 | 59 | Under 11 | $83K |
| Oxycodone Hcl Generic | 59 | 59 | 14 | $756 |
| Prednisone Generic | 57 | 71 | 14 | $520 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 45 | 45 | 16 | $1,017 |
| Hydroxyurea Generic | 42 | 93 | Under 11 | $653 |
| Xtandi Enzalutamide | 38 | 38 | Under 11 | $519K |
| Dexamethasone Generic | 38 | 38 | 19 | $391 |
| Calquence Acalabrutinib Maleate | 37 | 37 | Under 11 | $557K |
| Lenalidomide Generic | 37 | 37 | Under 11 | $461K |
| Orgovyx Relugolix | 33 | 33 | Under 11 | $82K |
Brand drugs: 508 claims; generic drugs: 1,070 claims; opioid claims: 124.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jeffrey M Stewart $55.88 ($55.88 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $55.88.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $55.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.